Antimicrobial Compound Screening
Antimicrobial Compound Screening - Related Videos
06:19
Galleria mellonella as an Antimicrobial Screening Model
0 Views •
Cited by 8 •
2024
This study presents a standardized framework for optimizing G. mellonella infection models for use in preclinical antimicrobial assessment. The application of a G. mellonella model as part of a preclinical antimicrobial development pipeline could decrease the number of ineffective compounds progressing to clinical trials.
03:37
A Deferred Growth Inhibition Assay to Evaluate the Effect of Bacteria-Derived Antimicrobial Compounds
0 Views •
2025
This video showcases the deferred growth inhibition assay, used to investigate how antimicrobial compounds produced by one type of bacteria affect another competing bacterial strain.
12:04
Thin-layer Chromatographic (TLC) Separations and Bioassays of Plant Extracts to Identify Antimicrobial Compounds
0 Views •
Cited by 52 •
2014
Methods are described for thin-layer chromatographic (TLC) separation of plant extracts and contact bioautography to identify antibacterial metabolites. The methods are applied to the screening of red clover phenolic compounds inhibiting hyper ammonia-producing bacteria (HAB) native to the bovine rumen.
01:23
Synergistic Antimicrobial Effect of Membrane-Targeting Compounds on Antibiotic-Resistant Bacteria
0 Views •
2026
Take suspensions of an antibiotic-resistant strain of a pathogenic bacterium.Treat one suspension with a short, membrane-disrupting antibiotic compound and the other with both the short compound and a longer, membrane-intercalating compound.Incubate both suspensions with agitation. These compounds mimic the lipid bilayer structure, enabling their spontaneous insertion into bacterial membranes.The short compound spans only part of the membrane’s thickness, creating a structural mismatch. This...
03:48
An In Vitro Broth Microdilution Assay for the Screening of Antifungal Compounds
0 Views •
2025
This video demonstrates an in vitro assay to screen antifungal compounds using a broth microdilution assay. Test compounds are serially diluted in a microtiter plate and incubated with a fungal inoculum. Post-incubation, the plate is examined for wells without visible fungal growth to assess the antifungal potential of the test compounds and their minimum inhibitory concentration (MIC).
FAQs
A dose-response relationship shows how changes in compound concentration correspond to changes in microbial growth, viability, or replication. Testing several defined concentrations allows researchers to compare the strength of activity across candidates rather than relying on a single measurement. These results help identify compounds that warrant further evaluation and support more informed prioritization.
Controls provide the reference needed to interpret changes observed after pathogen exposure to a compound. By comparing treated samples with appropriate controls, researchers can determine whether altered growth, viability, or replication is associated with the tested substance. This comparison strengthens conclusions about antimicrobial activity and helps distinguish meaningful effects from baseline assay behavior.
Potency describes how strongly a compound affects the infectious microorganism under the assay conditions, whereas selectivity addresses whether its activity is sufficiently directed toward the intended target rather than producing broader unwanted effects. Antimicrobial compound screening examines both properties so that highly active candidates can be assessed more carefully before advanced testing.
The workflow begins by exposing infectious microorganisms to defined concentrations of candidate compounds and including appropriate controls. Researchers then measure changes in growth, viability, or replication, compare results across concentrations, and examine the resulting dose response. Candidates showing useful activity can be compared for potency and selectivity before progressing to more advanced evaluation.
Researchers use this approach when they need to examine multiple substances under comparable assay conditions and determine which candidates produce the most useful antimicrobial effects. Measurements of growth, viability, or replication support direct comparison, while potency and selectivity assessments help prioritize compounds for subsequent testing and potential therapeutic development.
In this field, screening connects direct measurements of microorganism responses with broader questions about infection. Results can help researchers investigate host-pathogen interactions, examine issues related to antimicrobial resistance, and identify compounds for further therapeutic consideration. The approach therefore supports both mechanistic infection studies and the early prioritization of treatment candidates.